Determination of optimum number of cycles of induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a single-center retrospective study-Reference-Cited by-同舟云学术

Determination of optimum number of cycles of induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a single-center retrospective study

Published:2023-01-11 Issue:4 Volume:280 Page:1999-2006
ISSN:0937-4477
Container-title:European Archives of Oto-Rhino-Laryngology
language:en
Short-container-title:Eur Arch Otorhinolaryngol

Author:

Ahmed Abdullahi Omar,Wang Juan,Wu Qiuji,Zhong Yahua^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Otorhinolaryngology

Link

https://link.springer.com/content/pdf/10.1007/s00405-022-07794-w.pdf

Reference25 articles.

1. Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J (2019) Nasopharyngeal carcinoma. The Lancet 394(10192):64–80. https://doi.org/10.1016/S0140-6736(19)30956-0

2. Sung H et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660

3. Khor TH, Tan BC, Chua EJ, Chia KB (1978) Distant metastases in nasopharyngeal carcinoma. Clin Radiol 29(1):27–30. https://doi.org/10.1016/S0009-9260(78)80160-3

4. Al-Sarraf M et al (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16(4):1310–1317. https://doi.org/10.1200/JCO.1998.16.4.1310

5. Chan ATC et al (2002) Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol 20(8):2038–2044. https://doi.org/10.1200/JCO.2002.08.149

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The optimum number of induction chemotherapy cycles for N3M0 stage nasopharyngeal carcinoma based on pre-treatment plasma EBV DNA;2023-08-31

2. Optimum cycles of induction chemotherapy in concurrent chemo-radiotherapy management of unresectable stage III non-small cell lung cancer: Results from a single institutional database;Medicine;2023-05-12